Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...

▎药明康德内容团队编辑潜在首款，低剂量阿托品滴眼液递交新药申请Sydnexis今日宣布，美国FDA已受理该公司为在研疗法SYD-101提交的新药上市申请（NDA），预计在2025年10月23日之前完成审评。新闻稿指出，如果获批，SYD-101将成为美 ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...